IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
批准号:
6517381
负责人:
VICTOR E. REYES
金额:
$26.8万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-06-01 至 2004-05-31
关键词:
CD44 molecule Helicobacter MHC class II antigen antigen presentation antigen presenting cell bacterial antigens clinical research gastric mucosa gastrointestinal epithelium helper T lymphocyte host organism interaction human subject immunocytochemistry mucosal immunity neoplasm /cancer immunology phagocytosis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Helicobacter pylori is an important pathogen which plays the major role
in chronic gastritis, gastric and duodenal ulcers and gastric
carcinomas. Although H pylori infection of the gastric epithelium
elicits immune responses, insight into the mechanisms that regulate the
development of those responses is limited. Recent studies have suggested
that mucosal epithelial cells are active participants in immune
responses to mucosal pathogens. The antral gastric epithelium
constitutively expresses class II MHC molecules, and our cells have
shown that these epithelial cells express other important markers which
are required by antigen presenting cells. We noted that gastric
epithelial cells in vitro and in vivo expressed the CD86 co-stimulatory
molecule and this expression increased in parallel with the rise of
local CD4+ T cell numbers and epithelial class II MHC expression
increased in parallel with the rise of local CD4+ T cell numbers and
epithelial c;ass II MHC expression during infection with H. pylori. Our
most recent studies suggest that H pylori antigens are endocytosed by
gastric epithelial cells and transported into endosomes that contain
HLA-DM, a molecule which is essential in class II MHC-mediated antigen
presentation and immunity to pathogens. Thus, gastric epithelial cells
possess key functional elements of antigen presenting cells. Since
antigen processing and presentation are pivotal events in the
development of an immune response, our observations have led us to
hypothesize that gastric epithelial cells are central regulators of the
inflammatory and immunologic responses during H. pylori infection and
that the nature of those responses is influenced by the bacteria. To
examine this hypothesis we will address the following specific aims, as
natural extensions of the studies performed during the initial period of
funding.
1) Characterize the mechanisms of antigen internalization by gastric
epithelial cells. In this aim we will (a) characterize the H. pylori
antigens that are selectively internalized by human gastric epithelial
cells and the mechanisms that promote their uptake; (b) define how
internalized H. pylori antigens may alter various steps in the normal
antigen processing (steps) and (c) identify the H. pylori peptides that
are selective for presentation to T cells by gastric epithelial cells.
2) Characterize the mechanisms that allow gastric epithelial cells to
influence CD4+ T cell function. In this aim we will (a) define the
distribution of class II MHC in polarized gastric epithelial cells and
(b) characterize the expression and function of Ii-CS, an essential co-
receptor for CD44 on T cells, by human gastric epithelial cells.
The overall goal of these studies is to better understand the
interactions between H. pylori, the gastric epithelium and immune cells
that determine the outcome of the infection. The studies may help
explain why H. pylori infection persists and whether mechanisms that
allow H. pylori to evade immune defenses may also permit the associated
neoplasms to evade immune surveillance. Understanding the molecular
basis for the regulation of the local immune response to natural
infection will also facilitate the development of therapeutic or
prophylactic vaccines against this clinically important pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colonic myofibroblast activation of PD-1 pathways in inflammatory bowel diseases
-
批准号:8097751
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2010
-
负责人:VICTOR E. REYES
-
依托单位:
Immune Evasion by H. pylori
-
批准号:8145789
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2010
-
负责人:VICTOR E. REYES
-
依托单位:
Protein Biomarkers of Gastric Cancer
-
批准号:7589971
-
项目类别:
-
资助金额:$19.93万
-
财政年份:2009
-
负责人:VICTOR E. REYES
-
依托单位:
Protein Biomarkers of Gastric Cancer
-
批准号:7844854
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2009
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6177482
-
项目类别:
-
资助金额:$25.26万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6604093
-
项目类别:
-
资助金额:$27.6万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2151710
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6381031
-
项目类别:
-
资助金额:$26.02万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2430253
-
项目类别:
-
资助金额:$31.6万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2151711
-
项目类别:
-
资助金额:$29.64万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2758342
-
项目类别:
-
资助金额:$24.12万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF Ii CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:3456373
-
项目类别:
-
资助金额:$10.33万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF II CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:2069129
-
项目类别:
-
资助金额:$10.5万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF Ii CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:3456372
-
项目类别:
-
资助金额:$9.98万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF Ii CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:2069128
-
项目类别:
-
资助金额:$10.5万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
Ii CLEAVAGE AND RELEASE AND ANTIGEN PRESENTATION
-
批准号:2069127
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
国内基金
海外基金
高脂饮食诱导肠道微生物Helicobacter促进肠癌发生的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55.7万元
-
批准年份:2021
-
负责人:朱亚辉
-
依托单位:
研发纳米金材料改良免疫探测器用于定量分析污水中幽门螺旋杆菌(Helicobacter pylori, Hp)的新型流行病学研究
-
批准号:LQ22B050004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:卢鼎南
-
依托单位:
肥胖对Helicobacter suis感染后胃MALT淋巴瘤发生的影响及其炎性机制的研究
-
批准号:81572320
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:杨林
-
依托单位: